Turkmenistan Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Turkmenistan Health News.

Press releases published on August 13, 2026

Aug. 13, 2026

SS Innovations Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 13, 2026

Dogwood Therapeutics Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 13, 2026

Fate Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Aug. 13, 2026

Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 13, 2026

Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire

Aug. 13, 2026

WallabyPhenox Announces First Patient Enrolled in PROMISE Study Evaluating Treatment of Medium Vessel Occlusion Stroke

Indeterminate GlobeNewswire

Aug. 13, 2026

Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update

Indeterminate GlobeNewswire

Aug. 13, 2026

Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results

Indeterminate GlobeNewswire

Aug. 13, 2026

Eupraxia Pharmaceuticals Reports Symptom Response Data from its Ongoing Phase 1b/2a RESOLVE Trial, Including New Data on Odynophagia (Painful Swallowing) in Eosinophilic Esophagitis Patients

Indeterminate GlobeNewswire

Aug. 13, 2026

QTREX and U.S. Department of Defense Laboratory Target Q4 2026 to Formalize Joint Quantum Development Program

Indeterminate GlobeNewswire

Aug. 13, 2026

Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement 

Indeterminate GlobeNewswire

Aug. 13, 2026

Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit

Indeterminate GlobeNewswire

Aug. 13, 2026

Clearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint

Indeterminate GlobeNewswire

Aug. 13, 2026

Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 13, 2026

MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury

Indeterminate GlobeNewswire

Aug. 13, 2026

Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 13, 2026

Collegium Announces $50 Million Accelerated Share Repurchase Program

Indeterminate GlobeNewswire

Aug. 13, 2026

Cerenome Secures In-Network Agreement with Health Care Service Corporation, Expanding CNSide® Contracted Coverage to Over 150 Million Covered Lives

Indeterminate GlobeNewswire

Aug. 13, 2026

NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Aug. 13, 2026

Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire